adenocarcinoma

(redirected from adenocarcinoma of the lung)
Also found in: Thesaurus, Medical, Encyclopedia.

ad·e·no·car·ci·no·ma

 (ăd′n-ō-kär′sə-nō′mə)
n.
A malignant tumor originating in glandular tissue.

ad′e·no·car′ci·nom′a·tous (-nŏm′ə-təs, -nō′mə-təs) adj.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

adenocarcinoma

(ˌædɪnəʊˌkɑːsɪˈnəʊmə)
n, pl -mas or -mata (-mətə)
1. (Pathology) a malignant tumour originating in glandular tissue
2. (Pathology) a malignant tumour with a glandlike structure
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

ad•e•no•car•ci•no•ma

(ˌæd n oʊˌkɑr səˈnoʊ mə)

n., pl. -mas, -ma•ta (-mə tə)
1. a malignant tumor arising from secretory epithelium.
2. a malignant tumor of glandlike structure.
[1885–90]
ad`e•no•car`ci•nom′a•tous (-ˈnɒm ə təs, -ˈnoʊ mə-) adj.
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.adenocarcinoma - malignant tumor originating in glandular epitheliumadenocarcinoma - malignant tumor originating in glandular epithelium
carcinoma - any malignant tumor derived from epithelial tissue; one of the four major types of cancer
prostate cancer, prostatic adenocarcinoma - cancer of the prostate gland
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

ad·e·no·car·ci·no·ma

n. adenocarcinoma, cáncer maligno que se origina en una glándula.
English-Spanish Medical Dictionary © Farlex 2012

adenocarcinoma

n adenocarcinoma m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Kawasaki, et al., Small adenocarcinoma of the lung. Histologic characteristics and prognosis, Cancer 75 (1995) 2844-2852.
Diversity of gene expression ion adenocarcinoma of the lung. Proceedings of National Academy of Science USA.; 98(24): 13784-13789 (2001).
Extremely well differentiated papillary adenocarcinoma of the lung with prominent cilia formation.
The true papillary adenocarcinoma of the lung needs to be distinguished from primary and metastatic micropapillary adenocarcinoma of the other organ including breast, urinary bladder, ovary and salivary glands (2,3,6,8,13).
- The first patient has been dosed in the second stage of aphase II trial (BGBC008) evaluating Norwegian biopharmaceutical company BerGenBio ASA's (OSE: BGBIO) selective AXL inhibitor bemcentinib in combination with US-based pharmaceutical company Merck's (NYSE: MRK) anti-PD-1 therapy, Keytruda (pembrolizumab), in patients with previously treated advanced adenocarcinoma of the lung (non-small cell lung cancer, NSCLC) whose disease is progressing, the company said.
Adenocarcinoma of the lung in young patients: The M.
Unique genetic and survival characteristics of invasive mucinous adenocarcinoma of the lung. J Thorac Oncol 2015;10:1156-62.
The trial is enrolling patients with mesothelin-positive, relapsed/refractory Stage IIIB or Stage IV adenocarcinoma of the lung.
The patients were two white men aged 52 and 85 years with metastatic cutaneous melanoma and a 68-year-old African-American man with metastatic adenocarcinoma of the lung. All three patients were receiving anti-PD-1 and anti-PD-L1 monoclonal antibody therapy.
BerGenBio said the two-stage Phase II trial is an open label, multi-centre study of bemcentinib in combination with KEYTRUDA in patients with previously treated advanced adenocarcinoma of the lung (non-small cell lung cancer, NSCLC) whose disease is progressing.